Assignee
TITAN PHARMACEUTICALS INC
US·5 granted patents·20 pending applications·73 citations·filing 1999–2023
Top patents by PatentIndex Score
25 records- 0195US7736665B2Implantable polymeric device for sustained release of buprenorphineTITAN PHARMACEUTICALS INC·Filed 2003·Granted Jun 15, 2010·48 cites·9 claims
- 0280US2022241186A1Implantable polymeric device for sustained release of buprenorphineTITAN PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0379US10123971B2Heterogeneous implantable devices for drug deliveryTITAN PHARMACEUTICALS INC·Filed 2013·Granted Nov 13, 2018·6 cites·12 claims
- 0478US6565845B2Method for gene transfer to the central nervous systemTITAN PHARMACEUTICALS INC·Filed 2000·Granted May 20, 2003·6 cites·12 claims
- 0576US2023301902A1Implantable devices for drug delivery with reduced burst releaseTITAN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0674US2021046000A1Implantable polymeric device for sustained release of buprenorphineTITAN PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0771US2023165789A1Implantable devices for drug delivery with reduced burst releaseTITAN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0871US2019350842A1Implantable polymeric device for sustained release of buprenorphineTITAN PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0970US9278163B2Implantable polymeric device for sustained release of dopamine agonistTITAN PHARMACEUTICALS INC·Filed 2014·Granted Mar 8, 2016·1 cites·54 claims
- 1067US2014161860A1Implantable Polymeric Device for Sustained Release of BuprenorphineTITAN PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1167US2018177717A1Implantable polymeric device for sustained release of buprenorphineTITAN PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1267US2014171457A1Implantable Polymeric Device for Sustained Release of BuprenorphineTITAN PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1367US2014163057A1Implantable Polymeric Device for Sustained Release of BuprenorphineTITAN PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1467US2014088131A1Implantable Polymeric Device for Sustained Release of BuprenorphineTITAN PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1565US2008026031A1Implantable polymeric device for sustained release of buprenorphineTITAN PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1664US2016367477A1Implantable polymeric device for sustained release of buprenorphineTITAN PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1762US2014271765A1Methods and device for treating opioid addictionTITAN PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1862US2021007973A1Implantable devices for drug delivery with reduced burst releaseTITAN PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1962US2014271766A1Methods and device for treating opioid addictionTITAN PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2056US2006292128A1Methods of treating schizophreniaTITAN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2155US2024226226A1Kappa-opioid receptor agonist implants for treatment of pruritusTITAN PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2255US2021177742A1Loadable porous structures for use as implantsTITAN PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2353US2006089410A1Combination of chemotherapeutic drugs for increasing antitumor activityTITAN PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2452US2021113664A1Implants for release of lipophilic or amphiphilic pharmaceutical substancesTITAN PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2551US7115256B1Methods of treating schizophreniaTITAN PHARMACEUTICALS INC·Filed 1999·Granted Oct 3, 2006·12 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when TITAN PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →